Search

everythinglearnresearchcommunity

for

Search:↓

Advancements in male reproductive medicine are ongoing, but more research and improved treatments are needed in several areas.

PCOS affects many women, causing hormonal issues and health risks, but can be managed with lifestyle changes and medication.

Mutations in certain receptors can cause diseases and offer new treatment options.

Doxil showed some effectiveness against advanced prostate cancer but caused severe side effects at higher doses.

The document suggests that blocking sweat glands with antiperspirants might allow skin-generated hormones to be absorbed, possibly increasing breast and prostate cancer risk.

Some breast cancer chemotherapy can cause permanent hair loss.

A49T gene variant linked to higher prostate cancer risk, lower hormone levels, and slightly reduced balding risk.

Sex hormones may affect COVID-19 severity, with men often faring worse, and targeting related pathways could offer treatment options.

The conclusion suggests that prostate cancer should be classified by castration status and that new therapies targeting androgen receptor signaling show promise.

Scalp cooling helps prevent hair loss during chemotherapy, and minoxidil aids regrowth.

Hormone therapy for breast cancer often leads to sexual issues like vaginal dryness and decreased libido.

PTHrP and its receptor can control blood vessel growth and hair development in mouse skin.

PTHRP agonists can stimulate hair growth, especially in damaged follicles, while antagonists may initially increase growth but ultimately inhibit it.

Hair loss due to scalp metastasis from breast cancer, known as Neoplastic Alopecia, has a better survival rate than other scalp metastases and requires a biopsy for diagnosis.

Steroid-producing capabilities in certain cancers may contribute to treatment resistance.

Reproductive hormones play a crucial role in breast cancer development and treatment challenges.

CDK4/6 inhibitors have improved treatment outcomes for certain advanced breast cancer patients.

Men with a certain baldness pattern at age 40-50 may have a higher risk of aggressive prostate cancer.

Fadrozole and finasteride change gene expression related to sex hormones and thyroid hormones in frog larvae development.

Combined finasteride and anastrozole therapy effectively treats BPH, influenced by hormone imbalances and genetics.

Dermocosmetics help manage skin issues in cancer patients, improving outcomes and reducing treatment interruptions.

Hormone therapy affects cancer risks in transgender individuals differently than in cisgender people, and more research is needed to understand these risks and improve cancer screening guidelines.

Men with frontal male pattern baldness may have a higher risk of gastric cancer.

Anthracycline and taxane chemotherapy cause significant side effects like fatigue, vomiting, nausea, nerve damage, joint pain, and hair loss in breast cancer patients.

CDK4/6 inhibitors affect safety and quality of life differently, requiring careful use.

Human skin makes sexual hormones that affect hair growth, skin health, and healing; too much can cause acne and hair loss, while treatments can manage these conditions.

No definitive link between finasteride and male breast cancer, but further research is needed.

Androgen therapy can help with symptoms like low libido in women, but more research is needed to understand its long-term safety and effects on health.

An 86-year-old man with prostate cancer was diagnosed with a rare, low-grade breast cancer and underwent surgery but declined additional hormone therapy.

Dehydroepiandrosterone (DHEA) is a prohormone important for producing sex steroids and has potential health benefits.